Biotech Momentum Eases: September Is A Bit Sluggish By: TalkMarkets September 14, 2017 at 19:08 PM EDT Risks for biotech stocks and the healthcare sector, in general, are with Congress: drug pricing debate and/or lack of progress on tax reform. Read More >> Related Stocks: AbbVie Agios Pharmaceuticals Array Technologies Inc Bluebird Bio Cellectis S.A. ADR Clovis Oncology Inc Exelixis Inc HEALTHCARE Halozyme Therapeutic Incyte Corp Nasdaq Biotechnology Ishares ETF Pfizer Puma Biotechnology S&P Biotech SPDR Tesaro Inc